Metabolic Availability of Lysine From Barley in Young Adult Men
NCT ID: NCT03907020
Last Updated: 2025-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
7 participants
INTERVENTIONAL
2025-12-30
2027-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Availability of Lysine From Sorghum in Adult Men
NCT03411005
Metabolic Availability of Methionine and Lysine From Rice, Wheat, Chickpea and Lentil in Adult Men
NCT03674736
Metabolic Availability of Lysine From White Maize
NCT02018575
Lysine Metabolic Availability in Children
NCT04135040
Metabolic Availability of Metionine From Lentils in Adult Men
NCT03110913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adaptation days:
During days 1 and 2 the subjects will be adapted to the level of lysine being studied, consuming the same diet as they will receive on day 3 (IAAO study day). The adaptation diet will be consumed as 4 equal meals.Meals will be divided into 4 equal parts to be spread evenly throughout the day and consumed in their usual environment on their usual activities of daily living.
IAAO study day/isotope delivery and sample collection day:
On the oxidation study day 3, following a 12-h overnight fast, subjects will come to the Hospital for Sick Children, Toronto, ON for a period of 5.5 h. On the oxidation study day, the diet is consumed as 9 iso-nitrogenous and iso-energetic hourly meals. Between meals, subjects are allowed to rest on bed, watch television or use a computer. Study days for each participant will be separated by ≥ 1 week. For the duration of all experiments, subjects will consume a daily multivitamin (Centrum Forte, Whitehall Robins) and 500 mg choline supplement (Nature's Way or equivalent), to ensure adequate vitamin intake. The multi vitamin supplement is provided to ensure that no vitamin cofactors are limiting in the diet which could alter metabolic pathways and functioning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meabolic Availabiliy of Barley
Healthy adult men
Barley
Assessing the metabolic availability of lysine in barley.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Barley
Assessing the metabolic availability of lysine in barley.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable Body Weight (±0 to 5lb weight gain or loss in the last 3 months)
* Not on any medications that could affect protein or amino acid metabolism e.g. steroids.
Exclusion Criteria
* Recent history of weight loss within the last 3 months or on a weight reducing diet Inability to tolerate study diets (ex. Allergy to ingredients).
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Glenda Courtney-Martin
Dietitian
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Glenda Courtney-Martin, PhD
Role: PRINCIPAL_INVESTIGATOR
Associate Scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hospital For Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000060245
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.